Story perspectives

NIAID Shifts Focus, Experts Warn of Pandemic Vulnerability

2/18/2026

Summary

Story summary

The National Institute of Allergy and Infectious Diseases (NIAID) is deprioritizing biodefense and pandemic preparedness, per internal communications.
The shift aligns with a broader restructuring under acting director Jeffery Taubenberger.
Experts warn the change could leave the United States vulnerable to emerging infectious diseases and disrupt ongoing HIV/AIDS research.
The agency may redirect its budget from biodefense and pandemic preparedness toward basic immunology and chronic conditions, risking layoffs.

1 of 1

Story summary

The National Institute of Allergy and Infectious Diseases (NIAID) is deprioritizing biodefense and pandemic preparedness, per internal communications.
The shift aligns with a broader restructuring under acting director Jeffery Taubenberger.
Experts warn the change could leave the United States vulnerable to emerging infectious diseases and disrupt ongoing HIV/AIDS research.
The agency may redirect its budget from biodefense and pandemic preparedness toward basic immunology and chronic conditions, risking layoffs.